MedTech News
Stryker launches next-gen Mako suite
Stryker (NYSE: SYK) announced today that it is commercially launching the next generation of its Mako surgical robotic platform.
Sooma wins FDA IDE for neuromod tech that treats depression
Sooma Medical announced today that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation (tDCS) device.
Researchers uncover hidden barrier to spinal cord injury recovery
New research from the University of Kentucky has earned a spot on the cover of the Journal of Neuroscience, highlighting a major challenge in spinal cord injury recovery.
CRISPR cuts gene from head and neck cancers through direct injection—50% of tumors eliminated in animal models
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and successfully eliminated 50% of the tumors in model animals. This study was led by Dr. Razan Masarwy, MD, Ph.D. from the lab of Prof. Dan Peer. The findings are published in the journal Advanced Science.
Beneficial genetic changes observed in regular blood donors
Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells.
Miach Orthopaedics wins expanded FDA nod for Bear implant
Miach Orthopaedics announced today that the FDA cleared an expanded indication for the company’s Bear implant for ACL tears.
Lungpacer wins FDA IDE for AeroNova system
Lungpacer Medical announced today that it received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system.
Study: Tuberculosis relies on protective genes during airborne transmission
The findings provide new drug targets for stopping the infection’s spread.